Impact of COVID-19 lockdown on substance availability, accessibility, pricing, and quality : A multicenter study from India
Copyright: © 2022 Indian Journal of Psychiatry..
Background and Aim: Pandemic and consequent lockdowns are likely to affect the drug market by the sudden disruption of the supply chain. We explored the change in the availability, access, purity, and pricing during lockdown from respondents seeking treatment for drugs, alcohol, and tobacco dependence.
Materials and Methods: A cross-sectional survey was conducted among 404 respondents from seven treatment centers across India. A structured questionnaire assessed the change in availability, access, quality, and price of substances used during the first phase (March 24-April 14) and the second phase (April 15-May 3) of lockdown.
Results: A majority of the respondents in treatment used tobacco (63%) and alcohol (52%). Relatively few respondents used opioids (45%) or cannabis (5%). Heroin (44%) was the most common opioid the respondents were treated for. Seventy-five percent, 65%, and 60% of respondents treated for alcohol, tobacco, and opioid problems, respectively, reported a reduction in the availability and access during the first phase of the lockdown. In the second phase, respondents with alcohol and tobacco dependence reported greater availability than those with opioid and cannabis dependence. The reported price of all substances increased more than 50% during the first phase of lockdown and remained higher throughout the second phase. Deterioration in purity was reported by more than half of the people who used opioid.
Conclusion: Lockdown could have affected both licit and illicit drug markets, albeit to a varying degree. The observed changes seemed short-lasting, as suggested by the recovering trends during the second phase of lockdown.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
|---|---|
| Enthalten in: |
Indian journal of psychiatry - 64(2022), 5 vom: 29. Sept., Seite 466-472 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Arya, Sidharth [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 03.12.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.4103/indianjpsychiatry.indianjpsychiatry_864_21 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349706735 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349706735 | ||
| 003 | DE-627 | ||
| 005 | 20231226043249.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/indianjpsychiatry.indianjpsychiatry_864_21 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1165.xml |
| 035 | |a (DE-627)NLM349706735 | ||
| 035 | |a (NLM)36458079 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Arya, Sidharth |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of COVID-19 lockdown on substance availability, accessibility, pricing, and quality |b A multicenter study from India |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 03.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2022 Indian Journal of Psychiatry. | ||
| 520 | |a Background and Aim: Pandemic and consequent lockdowns are likely to affect the drug market by the sudden disruption of the supply chain. We explored the change in the availability, access, purity, and pricing during lockdown from respondents seeking treatment for drugs, alcohol, and tobacco dependence | ||
| 520 | |a Materials and Methods: A cross-sectional survey was conducted among 404 respondents from seven treatment centers across India. A structured questionnaire assessed the change in availability, access, quality, and price of substances used during the first phase (March 24-April 14) and the second phase (April 15-May 3) of lockdown | ||
| 520 | |a Results: A majority of the respondents in treatment used tobacco (63%) and alcohol (52%). Relatively few respondents used opioids (45%) or cannabis (5%). Heroin (44%) was the most common opioid the respondents were treated for. Seventy-five percent, 65%, and 60% of respondents treated for alcohol, tobacco, and opioid problems, respectively, reported a reduction in the availability and access during the first phase of the lockdown. In the second phase, respondents with alcohol and tobacco dependence reported greater availability than those with opioid and cannabis dependence. The reported price of all substances increased more than 50% during the first phase of lockdown and remained higher throughout the second phase. Deterioration in purity was reported by more than half of the people who used opioid | ||
| 520 | |a Conclusion: Lockdown could have affected both licit and illicit drug markets, albeit to a varying degree. The observed changes seemed short-lasting, as suggested by the recovering trends during the second phase of lockdown | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a India | |
| 650 | 4 | |a lockdown | |
| 650 | 4 | |a substance availability | |
| 650 | 4 | |a substance quality | |
| 700 | 1 | |a Ghosh, Abhishek |e verfasserin |4 aut | |
| 700 | 1 | |a Mishra, Shree |e verfasserin |4 aut | |
| 700 | 1 | |a Swami, Mukesh Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Prasad, Sambhu |e verfasserin |4 aut | |
| 700 | 1 | |a Somani, Aditya |e verfasserin |4 aut | |
| 700 | 1 | |a Basu, Aniruddha |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Kshitiz |e verfasserin |4 aut | |
| 700 | 1 | |a Padhy, Susanta Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Nebhinani, Naresh |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Lokesh Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Choudhury, Shinjini |e verfasserin |4 aut | |
| 700 | 1 | |a Basu, Debasish |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Rajiv |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Indian journal of psychiatry |d 1970 |g 64(2022), 5 vom: 29. Sept., Seite 466-472 |w (DE-627)NLM121097587 |x 0019-5545 |7 nnns |
| 773 | 1 | 8 | |g volume:64 |g year:2022 |g number:5 |g day:29 |g month:09 |g pages:466-472 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_864_21 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 64 |j 2022 |e 5 |b 29 |c 09 |h 466-472 | ||